Skip to main content

29-09-2019 | Chronic obstructive pulmonary disease | Video

ERS 2019: Exacerbation history remains best predictor of COPD exacerbations

Peter Calverley talks us through a post hoc analysis of the DYNAGITO trial looking at whether baseline eosinophil counts could help predict moderate-to-severe exacerbations in patients treated with corticosteroids for chronic obstructive pulmonary disease (5:30).

Funding for independent interviews at ERS 2019 was provided by F.Hoffmann-La Roche Ltd, Basel, Switzerland.